AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1413942 — intervention group
Group type: COMPARATOR
Intervention: Beta-sympathomimetics alone
Number of subjects: 114
Study 3937549 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine (60 mg, oral, twice daily)
Number of subjects: 0
Study 3937549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29800408 — intervention group
Group type: EXPERIMENTAL
Intervention: Choices (bilingual multi‐component intervention)
Number of subjects: 77
Study 29800408 — intervention group
Group type: COMPARATOR
Intervention: Control (general clinical trial information)
Number of subjects: 77
Study 27887597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ability Program (tablet-delivered cognitive activities 5 days/week, physical activities 7 days/week)
Number of subjects: 30
Study 27887597 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU) (paper and pencil cognitive activities 5 days/week, clinician's prescribed physical exercise daily)
Number of subjects: 30
Study 25008457 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence incentive intervention
Number of subjects: 147
Study 21933467 — intervention group
Group type: EXPERIMENTAL
Intervention: Training of family planning service providers in information exchange and training of their supervisors in facilitative supervision
Number of subjects: 0
Study 20420992 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered advance care planning (PC-ACP)
Number of subjects: 19
Study 20420992 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 19
Study 18184326 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate-specific antigen screening
Number of subjects: 87
Study 15918201 — intervention group
Group type: COMPARATOR
Intervention: Water drinking test
Number of subjects: 40
Study 15918201 — intervention group
Group type: COMPARATOR
Intervention: Nutritional beverage (Nutren) drinking test
Number of subjects: 40
Study 14971618 — intervention group
Group type: EXPERIMENTAL
Intervention: Gated blood pool SPECT (GBPS)
Number of subjects: 43
Study 14971618 — intervention group
Group type: COMPARATOR
Intervention: Planar radionuclide angiography (PRNA)
Number of subjects: 43
Study 11211124 — intervention group
Group type: EXPERIMENTAL
Intervention: Running at 35 degrees C
Number of subjects: 16
Study 11211124 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-km run at 35 degrees C
Number of subjects: 16
Study 11211124 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat storage at 35 degrees C
Number of subjects: 16
Study 11211124 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat storage at 25 degrees C
Number of subjects: 16
Study 11211124 — intervention group
Group type: EXPERIMENTAL
Intervention: Potential evaporation at 35 degrees C
Number of subjects: 16
Study 11211124 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased rate of heat production during 8-km run
Number of subjects: 16
Study 11211124 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean running speed during 8-km run
Number of subjects: 16
Study 9388311 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture treatment
Number of subjects: 64
Study 9388311 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (dextran, nicotinic acid, aspirin, dipyridamole, radix salviae miltiorrhizae composita)
Number of subjects: 64
Study 1417538 — intervention group
Group type: EXPERIMENTAL
Intervention: Optisol
Number of subjects: 62
Study 1417538 — intervention group
Group type: COMPARATOR
Intervention: DexSol
Number of subjects: 62
Study 6378807 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist
Number of subjects: 227
Study 6378807 — intervention group
Group type: EXPERIMENTAL
Intervention: Free questionnaire
Number of subjects: 227
Study 6378807 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional evaluation by physician
Number of subjects: 227
Study 31099300 — intervention group
Group type: COMPARATOR
Intervention: Blood serum markers (BDNF, IGF‐1, VEGF, TGF‐β 1, MCP‐1, IL‐18)
Number of subjects: 160
Study 29474410 — intervention group
Group type: EXPERIMENTAL
Intervention: PHQ-9 screening tool for depression
Number of subjects: 836
Study 27077879 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mL/day of PC-enriched OO containing 500 mg PC/kg (FVOO)
Number of subjects: 10
Study 27077879 — intervention group
Group type: COMPARATOR
Intervention: 25 mL/day of OO containing 80 mg PC/kg (VOO)
Number of subjects: 10
Study 27077879 — intervention group
Group type: COMPARATOR
Intervention: 25 mL/day of OO containing a mixture of 500 mg PC/kg from OO and thyme (FVOOT)
Number of subjects: 10
Study 25263837 — intervention group
Group type: COMPARATOR
Intervention: Online support (resources plus website and e-feedback)
Number of subjects: 0
Study 25263837 — intervention group
Group type: COMPARATOR
Intervention: Self-help paper-based resources (gender-tailored weight loss resources including DVD, handbooks, pedometer, tape measure)
Number of subjects: 0
Study 22422361 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir 250 mg suspension
Number of subjects: 42
Study 22422361 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg tablet
Number of subjects: 42
Study 22422361 — intervention group
Group type: COMPARATOR
Intervention: Placebo suspension
Number of subjects: 42
Study 21252455 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course acyclovir therapy (800 mg five times a day for four days)
Number of subjects: 152
Study 17279850 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants rated fictional partners in happier relationships
Number of subjects: 0
Study 17279850 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants' judgments of their own current partners
Number of subjects: 0
Study 17279850 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaperceptions of bias in couples
Number of subjects: 0
Study 17279850 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive bias for traits relevant to mate evaluation
Number of subjects: 0
Study 11246613 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha-2b, 3 MU three times a week for 6 months (group 1)
Number of subjects: 80
Study 11246613 — intervention group
Group type: COMPARATOR
Intervention: No treatment (group 2)
Number of subjects: 80
Study 11246613 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha-2b (group 1)
Number of subjects: 80
Study 9307221 — intervention group
Group type: EXPERIMENTAL
Intervention: poly(L-lactide) osteosynthesis plug
Number of subjects: 15
Study 8354200 — intervention group
Group type: EXPERIMENTAL
Intervention: 5000 IU of vitamin A
Number of subjects: 177
Study 8354200 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 IU of vitamin E
Number of subjects: 177
Study 8354200 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of vitamins A and E (5000 IU + 100 IU)
Number of subjects: 177
Study 8354200 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg of beta-carotene
Number of subjects: 177
Study 8354200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study 2872913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracapsular extraction and contact lens usage (Group A)
Number of subjects: 333
Study 2872913 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracapsular extraction and implantation of an iridocapsular lens (Group C)
Number of subjects: 333
Study 2872913 — intervention group
Group type: COMPARATOR
Intervention: Intracapsular extraction and implantation of an iris supported lens (Federov I) (Group B)
Number of subjects: 333
Study 2872913 — intervention group
Group type: EXPERIMENTAL
Intervention: Both implant groups (Groups B and C)
Number of subjects: 333
Study 30789384 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol 0.7 g/kg
Number of subjects: 204
Study 30789384 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol 1.0 g/kg
Number of subjects: 204
Study 30789384 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol 1.4 g/kg
Number of subjects: 204
Study 30789384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 27425388 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism adaptation (PA)
Number of subjects: 43
Study 27425388 — intervention group
Group type: COMPARATOR
Intervention: Placebo prism training
Number of subjects: 43
Study 27754419 — intervention group
Group type: EXPERIMENTAL
Intervention: 6mg/kg of caffeine
Number of subjects: 20
Study 27754419 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 24622117 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothyroid patients
Number of subjects: 4987
Study 24622117 — intervention group
Group type: COMPARATOR
Intervention: Euthyroid patients
Number of subjects: 4987
Study 24622117 — intervention group
Group type: EXPERIMENTAL
Intervention: After adjustment for other predictors
Number of subjects: 4987
Study 22914404 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod
Number of subjects: 59
Study 22914404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 20026804 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine 75 mg/m²/d
Number of subjects: 113
Study 20026804 — intervention group
Group type: COMPARATOR
Intervention: Conventional care regimens (CCR)
Number of subjects: 113
Study 20026804 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine
Number of subjects: 113
Study 20026804 — intervention group
Group type: COMPARATOR
Intervention: CCR
Number of subjects: 113
Study 18449445 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine-enhanced formula
Number of subjects: 44
Study 18449445 — intervention group
Group type: COMPARATOR
Intervention: Standard polymeric formula
Number of subjects: 44
Study 18449445 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine, RNA and omega-3 fatty acids enhanced formula
Number of subjects: 44
Study 18449445 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 44
Study 18449445 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 44
Study 18449445 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced diet groups
Number of subjects: 44
Study 16001233 — intervention group
Group type: EXPERIMENTAL
Intervention: Tesaglitazar 1.0 mg/day
Number of subjects: 390
Study 12556267 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-implant overdenture
Number of subjects: 30
Study 12556267 — intervention group
Group type: COMPARATOR
Intervention: Conventional complete dentures
Number of subjects: 30
Study 10657821 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal live attenuated influenza vaccine
Number of subjects: 1358
Study 10657821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1358
Study 8665355 — intervention group
Group type: EXPERIMENTAL
Intervention: Portocaval or splenorenal anastomosis (group I)
Number of subjects: 232
Study 8665355 — intervention group
Group type: COMPARATOR
Intervention: Esophageal transection or variceal sclerosis (group II)
Number of subjects: 232
Study 1500660 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate
Number of subjects: 0
Study 1500660 — intervention group
Group type: COMPARATOR
Intervention: Other antacids (magnesium hydroxide and aluminum hydroxide)
Number of subjects: 0
Study 31815528 — intervention group
Group type: EXPERIMENTAL
Intervention: HASMEP-T (HIV/AIDS self-management education program)
Number of subjects: 40
Study 27927683 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium Nitrate (KNO3)
Number of subjects: 12
Study 27927683 — intervention group
Group type: COMPARATOR
Intervention: Potassium Chloride (Control)
Number of subjects: 12
Study 25765698 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic plus community support (screening for serum cryptococcal antigen, antifungal therapy for positive cases, weekly home visits for 4 weeks)
Number of subjects: 1999
Study 25765698 — intervention group
Group type: COMPARATOR
Intervention: Standard care (clinic-based care alone)
Number of subjects: 1999
Study 25765698 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic plus community support
Number of subjects: 1999
Study 25765698 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1999
Study 23340440 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) gel, 0.5mL injection
Number of subjects: 60
Study 23340440 — intervention group
Group type: COMPARATOR
Intervention: Isotonic sodium chloride (control)
Number of subjects: 60
Study 21795436 — intervention group
Group type: EXPERIMENTAL
Intervention: Fragmented sleep
Number of subjects: 15
Study 21795436 — intervention group
Group type: COMPARATOR
Intervention: Nonfragmented sleep
Number of subjects: 15
Study 19386741 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligofructose supplementation (21 g/d)
Number of subjects: 48
Study 19386741 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 48
Study 18596121 — intervention group
Group type: EXPERIMENTAL
Intervention: multitarget therapy (mycophenolate mofetil, tacrolimus, and steroids)
Number of subjects: 40
Study 18596121 — intervention group
Group type: COMPARATOR
Intervention: intravenous cyclophosphamide (IVCY)
Number of subjects: 40
Study 16000607 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (cisplatin-based)
Number of subjects: 150
Study 16000607 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 150
Study 16000607 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 150
Study 12638280 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with IBS seeking medical assistance
Number of subjects: 338
Study 12638280 — intervention group
Group type: COMPARATOR
Intervention: General population with IBS symptoms
Number of subjects: 338
Study 12638280 — intervention group
Group type: COMPARATOR
Intervention: General population
Number of subjects: 338
Study 12638280 — intervention group
Group type: COMPARATOR
Intervention: IBS subjects
Number of subjects: 338
Study 10624645 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuffed oropharyngeal airway (COPA)
Number of subjects: 60
Study 10624645 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 60
Study 7555938 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous endoscopic gastrostomy (PEG)
Number of subjects: 22
Study 7555938 — intervention group
Group type: COMPARATOR
Intervention: 15-French tube
Number of subjects: 22
Study 7555938 — intervention group
Group type: COMPARATOR
Intervention: 20-French tube
Number of subjects: 22
Study 1951163 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish-oil concentrate (FOC) supplemented with 15 mg alpha-tocopherol/d for 10 weeks
Number of subjects: 0
Study 1951163 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish-oil concentrate (FOC) plus an additional 200 mg alpha-tocopherol/d for 8 weeks (FOC+E)
Number of subjects: 0
Study 1951163 — intervention group
Group type: COMPARATOR
Intervention: Placebo oil (PO) for 10 weeks
Number of subjects: 0
Study 7033573 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol during chemotherapy
Number of subjects: 143
Study 7033573 — intervention group
Group type: COMPARATOR
Intervention: Control (no allopurinol) during chemotherapy
Number of subjects: 143
Study 29343089 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciprocal peer support arm
Number of subjects: 102
Study 29343089 — intervention group
Group type: COMPARATOR
Intervention: Nurse care management arm
Number of subjects: 102
Study 27910203 — intervention group
Group type: EXPERIMENTAL
Intervention: Designing and conducting DNA extraction with household materials
Number of subjects: 47
Study 26186592 — intervention group
Group type: EXPERIMENTAL
Intervention: Rikkunshito 7.5 g/day
Number of subjects: 21
Study 26186592 — intervention group
Group type: EXPERIMENTAL
Intervention: Rikkunshito 5.0 g/day
Number of subjects: 21
Study 26186592 — intervention group
Group type: EXPERIMENTAL
Intervention: Rikkunshito 2.5 g/day
Number of subjects: 21
Study 23855301 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord-derived mesenchymal stem cell (UC-MSC) transfusion, 0.5×10^6 cells/kg body weight, infused three times at 4-week intervals.
Number of subjects: 7
Study 23855301 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord-derived mesenchymal stem cell (UC-MSC) transfusion
Number of subjects: 7
Study 20662674 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-aligning attachment system
Number of subjects: 25
Study 20662674 — intervention group
Group type: COMPARATOR
Intervention: Traditional ball attachment system
Number of subjects: 25
Study 19552918 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmentally appropriate face identity aftereffect (FIAE) task
Number of subjects: 0
Study 19552918 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation to facial identity
Number of subjects: 0
Study 17467914 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Enteral Nutrition (TEN)
Number of subjects: 19
Study 15179174 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate supplementation (C)
Number of subjects: 16
Study 15179174 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 16
Study 11570735 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented feedback
Number of subjects: 63
Study 11570735 — intervention group
Group type: COMPARATOR
Intervention: Sensory feedback
Number of subjects: 63
Study 11570735 — intervention group
Group type: COMPARATOR
Intervention: Control I
Number of subjects: 63
Study 11570735 — intervention group
Group type: COMPARATOR
Intervention: Control II
Number of subjects: 63
Study 9748036 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular exercises
Number of subjects: 39
Study 9748036 — intervention group
Group type: COMPARATOR
Intervention: Control (no vestibular exercises)
Number of subjects: 39
Study 7872714 — intervention group
Group type: EXPERIMENTAL
Intervention: p53-positive leukemic cells
Number of subjects: 91
Study 7872714 — intervention group
Group type: COMPARATOR
Intervention: p53-negative leukemic cells
Number of subjects: 91
Study 3337013 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise training (65 to 75% VO2max)
Number of subjects: 45
Study 3337013 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise training (less than 45% VO2max)
Number of subjects: 45
Study 3337013 — intervention group
Group type: COMPARATOR
Intervention: Both groups (high and low intensity)
Number of subjects: 45
Study 29855452 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration exercise
Number of subjects: 0
Study 29855452 — intervention group
Group type: EXPERIMENTAL
Intervention: Chair rising time
Number of subjects: 0
Study 27105601 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (30 mg)
Number of subjects: 60
Study 27105601 — intervention group
Group type: COMPARATOR
Intervention: Chlordiazepoxide (75 mg)
Number of subjects: 60
Study 25656258 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue adhesive (TA) with standard polyurethane dressing (SPU)
Number of subjects: 85
Study 25656258 — intervention group
Group type: EXPERIMENTAL
Intervention: Bordered polyurethane dressing (BPU) with SPU
Number of subjects: 85
Study 25656258 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless securement device (SSD) with SPU
Number of subjects: 85
Study 25656258 — intervention group
Group type: COMPARATOR
Intervention: Standard polyurethane dressing (SPU)
Number of subjects: 85
Study 24362707 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D2 supplementation (vitD2, 3800 IU/day)
Number of subjects: 28
Study 24362707 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 21916687 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based social competence intervention
Number of subjects: 1675
Study 21916687 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental training intervention
Number of subjects: 1675
Study 21916687 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 1675
Study 21916687 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1675
Study 19001508 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg per day
Number of subjects: 4128
Study 19001508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4128
Study 15917194 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (1 g intravenous infusion for 45 min)
Number of subjects: 10
Study 15917194 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intravenous infusion)
Number of subjects: 10
Study 12011684 — intervention group
Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy for complications of BRVO
Number of subjects: 0
Study 10433012 — intervention group
Group type: EXPERIMENTAL
Intervention: Recumbent posture
Number of subjects: 11
Study 10433012 — intervention group
Group type: COMPARATOR
Intervention: Upright posture
Number of subjects: 11
Study 8942013 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of calcium, vitamin D3, and ascorbic acid supplementation
Number of subjects: 25
Study 8942013 — intervention group
Group type: COMPARATOR
Intervention: Lactose as a placebo
Number of subjects: 25
Study 1705725 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionated radiation (Group I); 1.8 to 2.3 Gy once a day, total dose 30 to 40 Gy, average treatment duration 20 days
Number of subjects: 55
Study 1705725 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation (Group II); 1.8 to 2 Gy two times a day, total dose 25 to 35 Gy, average treatment duration 10 days
Number of subjects: 55
Study 6751059 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary thrombolysis
Number of subjects: 0
Study 6751059 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient entry within 3 hours of onset of infarction
Number of subjects: 0
Study 30267478 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (0.2 mg/kg i.v., maximum 8 mg)
Number of subjects: 87
Study 30267478 — intervention group
Group type: COMPARATOR
Intervention: Label dosing of Diazepam
Number of subjects: 87
Study 30267478 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam
Number of subjects: 87
Study 26815798 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Care (KC)
Number of subjects: 231
Study 26815798 — intervention group
Group type: COMPARATOR
Intervention: Auditory-Tactile-Visual-Vestibular (ATVV) intervention
Number of subjects: 231
Study 26815798 — intervention group
Group type: COMPARATOR
Intervention: Preterm infant care information
Number of subjects: 231